Thompson Siegel & Walmsley LLC Regeneron Pharmaceuticals, Inc. Transaction History

Thompson Siegel & Walmsley LLC

$6.71 Billion
Q3 2024

A detailed history of Thompson Siegel & Walmsley LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Thompson Siegel & Walmsley LLC holds 7,490 shares of REGN stock, worth $5.22 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

7,490

Previous 8,614 13.05%

Holding current value

$5.22 Million

Previous $9.05 Million 13.03%

% of portfolio

0.12%

Previous 0.15%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$1024.09 - $1201.76 $1.15 Million - $1.35 Million	-1,124 Reduced 13.05%	7,490 $7.87 Million
Q2 2024 Aug 08, 2024	SELL	$883.2 - $1071.19 $102,451 - $124,258	-116 Reduced 1.33%	8,614 $9.05 Million
Q1 2024 May 09, 2024	SELL	$902.69 - $993.35 $2.19 Million - $2.41 Million	-2,431 Reduced 21.78%	8,730 $8.4 Million
Q4 2023 Feb 07, 2024	SELL	$775.18 - $881.7 $474,410 - $539,600	-612 Reduced 5.2%	11,161 $9.8 Million
Q3 2023 Nov 08, 2023	BUY	$692.45 - $844.37 $233,355 - $284,552	337 Added 2.95%	11,773 $9.69 Million
Q2 2023 Aug 10, 2023	BUY	$700.03 - $830.35 $14,700 - $17,437	21 Added 0.18%	11,436 $8.22 Million
Q1 2023 May 11, 2023	BUY	$680.49 - $826.97 $287,847 - $349,808	423 Added 3.85%	11,415 $9.38 Million
Q4 2022 Feb 10, 2023	BUY	$705.89 - $766.39 $7.76 Million - $8.42 Million	10,992 New	10,992 $7.93 Million
Q3 2022 Oct 25, 2022	SELL	$573.97 - $724.32 $55,101 - $69,534	-96 Reduced 0.83%	11,403 $7.86 Million
Q2 2022 Jul 22, 2022	BUY	$548.35 - $738.84 $19,192 - $25,859	35 Added 0.31%	11,499 $6.8 Million
Q1 2022 Apr 26, 2022	BUY	$595.12 - $698.43 $42,253 - $49,588	71 Added 0.62%	11,464 $8.01 Million
Q4 2021 Feb 09, 2022	BUY	$543.48 - $670.97 $170,109 - $210,013	313 Added 2.82%	11,393 $7.2 Million
Q3 2021 Nov 05, 2021	BUY	$574.03 - $680.96 $134,897 - $160,025	235 Added 2.17%	11,080 $6.71 Million
Q2 2021 Aug 09, 2021	BUY	$472.8 - $558.54 $5.13 Million - $6.06 Million	10,845 New	10,845 $6.06 Million
Q2 2018 Aug 09, 2018	SELL	$284.6 - $344.99 $11,668 - $14,144	-41 Closed	0 $0
Q2 2017 Aug 09, 2017	BUY	N/A	41	41 $20,000

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

82.7M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.

Account

Thompson Siegel & Walmsley LLC Regeneron Pharmaceuticals, Inc. Transaction History